|
Re: Video on BET inhibition in renal and cardiovascular disease
|
3
|
Resverlogix Corp.
|
Sep 24, 2019 01:00PM
|
|
Re: News !!!
|
3
|
Resverlogix Corp.
|
Feb 27, 2018 06:58AM
|
|
Resverlogix Announces US$30 Million Loan Commitment Letter
|
3
|
Resverlogix Corp.
|
Apr 11, 2018 08:25AM
|
|
Re: Repurposing Medications for Treatment of Pulmonary Arterial Hypertension: What’s Old Is New Again
|
3
|
Resverlogix Corp.
|
Feb 02, 2019 12:17PM
|
|
Re: Inflection Points: Resverlogix and Zenith
|
3
|
Resverlogix Corp.
|
Jun 14, 2016 01:40PM
|
|
Re: Resverlogix Announces Closing of $15 Million Offering
|
3
|
Resverlogix Corp.
|
Jun 07, 2019 09:55AM
|
|
Re: The MD@A for the period ending July 31, 2017
|
3
|
Resverlogix Corp.
|
Sep 14, 2017 10:39AM
|
|
Re: Trial
|
3
|
Zenith Epigenetics
|
Sep 18, 2016 02:59PM
|
|
Re: The journey to the finish line
|
3
|
Resverlogix Corp.
|
May 12, 2018 12:36PM
|
|
Re: 9 consecutive trading days
|
3
|
Resverlogix Corp.
|
May 24, 2018 11:01AM
|
|
Re: Tensha Therapeutics sold to Roche
|
3
|
Zenith Epigenetics
|
Jan 12, 2016 03:00PM
|
|
Re: 250 MACE scenario question
|
3
|
Resverlogix Corp.
|
Jan 23, 2019 07:59PM
|
|
Re: 2019 Potential Events
|
3
|
Resverlogix Corp.
|
Apr 02, 2019 01:50PM
|
|
Re: Checking the chart and seeing another pennant, contractions coming quicker....
|
3
|
Resverlogix Corp.
|
May 12, 2019 12:02PM
|
|
Re: RVX in the next 5 weeks
|
3
|
Resverlogix Corp.
|
Aug 20, 2016 08:43AM
|
|
Re: trial no 2
|
3
|
Zenith Epigenetics
|
Oct 30, 2016 04:32PM
|
|
Re: Total Patient Hours Question
|
3
|
Resverlogix Corp.
|
Sep 16, 2019 05:43PM
|
|
Re: Can Apabetalone be used,
|
3
|
Resverlogix Corp.
|
Nov 07, 2019 10:24AM
|
|
Re: Setting expectations....
|
3
|
Resverlogix Corp.
|
Jun 22, 2018 03:51PM
|
|
Re: ESC Poster on Vascular Inflammation, Calcification and Plaque Vulnerability
|
3
|
Resverlogix Corp.
|
Sep 03, 2019 05:09PM
|
